Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Hematocrit

RABGAP1L · rs6688577

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−10, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 737,823 African American or Afro-Caribbean, African ancestry, European ancestry, East Asian ancestry, Hispanic or Latin American and South Asian ancestry individuals.

The effect The reported allele is T; the catalogue records no effect size ; p = 2 × 10−10.

How common The T allele had a frequency of about 38% in the people studied.

Where it sits Chromosome 1, band 1q25.1 — in an intron of RABGAP1L.

How common each version is

CT
Korean KRGDB
C 66.9% · T 33.1%
Korean Korea4K
C 67.0% · T 33.0%
Korean Korea1K
C 66.2% · T 33.8%
Japanese ToMMo
C 68.6% · T 31.4%
Vietnamese
C 79.7% · T 20.3%
World gnomAD
C 48.5% · T 51.5%
World 1000 Genomes
C 47.9% · T 52.1%
World TOPMed
C 47.0% · T 53.0%

By ancestry gnomAD

East Asian
C 70.9% · T 29.1%
European (non-Finnish)
C 61.7% · T 38.3%
African / African American
C 16.8% · T 83.2%
South Asian
C 58.9% · T 41.1%
Admixed American (Latino)
C 57.4% · T 42.6%
Middle Eastern
C 48.6% · T 51.4%
Finnish
C 60.3% · T 39.7%
Ashkenazi Jewish
C 46.7% · T 53.3%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C No copy of the version the research linked to Hematocrit. This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to Hematocrit. That is a smaller link than two copies.
T/T Two copies of the version the research linked to Hematocrit. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Hematocrit (rs6688577). MyGeneLog™. https://www.mygenelog.com/variants/rs6688577

← See all variants